Holistic Management Of Pulmonary Tb With Antituberculous Drugs Allergic, Type 2 Diabetes Mellitus And 1st Grade Obesity In A Women Aged 54 Years Old Through A Family Medicine Approach
DOI:
https://doi.org/10.53089/medula.v13i2.500Keywords:
family medicine, pulmonary TB, Diabetes mellitus, Obesity, Holistic managementAbstract
In 2020 as many as 1,3 million peoples in the world died due to TB. In 2021 Lampung Province was ranked 9th in Indonesia. One of the challenges in TB treatment is the side effects of major drugs such as OAT allergies. Allergic drug eruption or adverse cutaneous drug eruption is a hypersensitivity reaction of the body to drugs with skin manifestations that can be accompanied by mucosal involvement. Patients with Diabetes Mellitus (DM) have a tendency to be twice as likely to be infected with pulmonary TB disease than individuals without diabetes because the body is in an immunocompromised condition. Obesity is a condition in which a person's body has fat levels that are too high and can cause various health problems, one of which is DM.. Patients must know about their disease and have the awareness and motivation to complete treatment and lifestyle modifications so that treatment goals can be achieved. The study is a case report. Primary data were obtained through history taking, physical examination and home visits. Secondary data were obtained from the patient's medical record at the Puskesmas. Assessment is carried out based on a holistic diagnosis from the beginning, process, and end of the study quantitatively and qualitatively. Patient Mrs. T has a complaint of swollen lips and tongue accompanied by a red rash on the skin all over the body since 2 days ago. Three days ago, the patient came to the Puskesmas for control of TB treatment which had finished the intensive phase and moved to the advanced phase. After the intervention based on Evidence-Based Medicine with patient-centered, family approach and community medicine, there was a decrease in clinical symptoms and an increase in the knowledge of patients and her families.
References
World Health Organization (WHO). Global Tuberculosis Report 2021. Geneva; 2021.
Kemenkes RI. Data dan Informasi Kementerian Kesehatan RI : Tuberkulosis. Jakarta; 2021.
Ramadhayanti DA, Cahyo K, Widagdo L. Faktor-Faktor yang Mempengaruhi Pencegahan Kejadian Drop Out Tuberkulosis Pada Keluarga di Seluruh Wilayah Kerja Puskesmas Kota Semarang. J Kesehat Masy [Internet]. 2018;6(2):163–9. Available from: http://ejournal3.undip.ac.id/index.php/jk
Nurmadya, Medison I, Bachtiar H. Hubungan Pelaksanaan Strategi Directly Observed Treatment Short Course dengan Hasil Pengobatan Tuberkulosis Paru Puskesmas Padang Pasir Kota Padang 2011-2013. J Kesehat Andalas [Internet]. 2015;4(1):207–11. Available from: http://jurnal.fk.unand.ac.id
Badan Litbang Kesehatan. LAPORAN PROVINSI LAMPUNG RISKESDAS 2018. 2019.
Kementerian Kesehatan RI. Profil Kesehatan Indonesia 2021. Jakarta; 2022.
Kementerian Kesehatan RI. Pedoman Nasional Pelayanan Kedokteran : Tata Laksana Tuberkulosis. Jakarta; 2020.
Menaldi SL, Bramono K, Indriatmi W. Ilmu Penyakit Kulit dan Kelamin. Edisi ketu. Jakarta: Badan Penerbit Fakultas Kedokteran Indonesia; 2018. 190-195 p.
Mahmuda INN, Putra MAS. Reaksi Alergi Obat pada Pasien Tuberculosis Paru dengan Gambaran Radiologi Menyerupai Pancoast Tumor; Tantangan Diagnosis dan Terapi. J Kedokt UMS. 2020;199–206.
Sudoyo, Setyohadi, Alwi, Simadibrata, Setiati. Buku Ajar Ilmu Penyakit Dalam. Jilid 1. Edisi VI. Jakarta: Interna Publishing; 2015.
PERKENI. Pedoman Pengelolaan dan Pendcegahan Diabetes Melitus Tipe 2 di Indonesia. In Jakarta: PB. PERKENI; 2021.
Novita E, Ismah Z, Pariyana P. Angka kejadian diabetes melitus pada pasien tuberkulosis. J Kedokt dan Kesehat Fak Kedokt Univ Sriwij. 2018;5(1):20–5.
Nasir M, Program MP, Hospital A, Tadulako U. Tuberculosis Multidrug-Resistant pada Diabetes Mellitus Tipe 2 (Multidrug-Resistant Tuberculosis in Diabetes Mellitus Type 2). J Med Prof. 2020;2(3):235–42.
Kemenkes RI. Buku Pedoman Manajeman Penyakit Tidak Menular. Jakarta; 2019.
Kemenkes RI. Hasil Utama Riskesdas 2018. Jakarta; 2018.
Kemenkes RI. Pedoman Nasional Pelayanan Kedokteran Tatalaksana Diabetes Melitus Tipe 2 Dewasa. Jakarta: Kementerian Kesehatan RI; 2020.
Kreisel C, Passannante M, Lardizabal A. The negative clinical impact of diabetes on tuberculosis: A cross-sectional study in New Jersey. J Endocr Soc. 2019;3(1):62–8.
Liu Q, LI W, Xue M, Chen Y, Du X, Wang C. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Respir. 2017;7(1):1090.
Masi G, Oroh W. Hubungan Obesitas dengan Kejadian Diabetes Melitus di Wilayah Kerja Puskesmas Ranomut Kota Manado. e-journal Keperawatan Fak Kedokt Univ Sam Ratulangi. 2018;6(1):1–6.
Kemenkes RI. Penanggulangan Tuberkulosis. Peraturan Menteri Kesehatan Republik Indonesia Nomor 67 Tahun 2016. In Jakarta; 2016.
Kemenkes RI. Infodatin Tuberkulosis : Temukan Obati Sampai Sembuh. Jakarta; 2020.
Patterson B, Morrow C, Singh V, Moosa A, Ggada M. Detection of Mycobacterium tuberculosis bacilli in bio-aerosols from untreated TB patients. Gate Open Resp. 2017;1(11).
Fiannisa R. Case Reports : Studi Efek Samping OAT pada Pasien Tuberculosis dengan Diabetes Melitus Tipe 2 dan Anemia. J Sains Farm. 2022;3(1):30–7.
Departemen Kesehatan RI. Pharmaceutical care untuk penyakit tuberkulosis. Pharm World Sci. 2005;18(6):233–5.
Saftarina F. Case Report : Type 2 Diabetes Mellitus for The Elderly with Less Family Support. Rev Prim Care Pract Educ. 2021;4(2):1–8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
